Role of sorbitol pathway in neuropathy.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000378:metabolism* / Q000503:physiopathology; D004195:Disease Models, Animal; D005632:Fructose / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000037:antagonists & inhibitors; D005690:Galactose / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009431:Neural Conduction; D010629:Phenformin / Q000627:therapeutic use; D051381:Rats; D012584:Sciatic Nerve / Q000378:metabolism / Q000503:physiopathology; D013012:Sorbitol / Q000378:metabolism*; D013311:Streptozocin
D001786:Blood Glucose; D007328:Insulin; D005632:Fructose; D013012:Sorbitol; D013311:Streptozocin; D010629:Phenformin; D005634:Fructose-Bisphosphate Aldolase; D005947:Glucose; D005690:Galactose